Cargando…
Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients
Sumatriptan is a selective agonist of 5HT1 (1B/1D) receptors, which has proved to be effective and safe for the acute treatment of migraine attacks. Nevertheless, its use by migraine sufferers is still limited and some patients consider adverse reactions related to sumatriptan, especially chest symp...
Autores principales: | Sternieri, E., Pinetti, D., Coccia, C. P. R., Leone, S., Bertolini, A., Ferrari, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452017/ https://www.ncbi.nlm.nih.gov/pubmed/16362699 http://dx.doi.org/10.1007/s10194-005-0220-z |
Ejemplares similares
-
Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype
por: Dalla Volta, G., et al.
Publicado: (2005) -
Weight variations in the prophylactic therapy of primary headaches: 6–month follow–up
por: Maggioni, F., et al.
Publicado: (2005) -
Headache and botulinum toxin
por: Porta, M., et al.
Publicado: (2005) -
Acute Migraine Therapy: New Drugs and New Approaches
por: Monteith, Teshamae S., et al.
Publicado: (2010) -
Vestibular migraine
por: Silva, Viviane Passarelli Ramin, et al.
Publicado: (2022)